Peter Attia MD395 – Brain lipidology: understanding APOE, cholesterol homeostasis, Alzheimer’s disease, & more
At a glance
WHAT IT’S REALLY ABOUT
Brain Cholesterol Works Separately From Blood Lipids, and APOE4 Disrupts It
- Dayspring explains that peripheral cholesterol travels in apoB and apoA lipoproteins, that most body cholesterol sits in cells rather than plasma, and that lowering plasma LDL does not meaningfully deplete body or brain cholesterol.
- The brain holds far more cholesterol than any other organ, makes it locally (oligodendrocytes and astrocytes, with neurons stopping synthesis around age 10), and moves it using apoE-containing HDL-like particles that apoB particles cannot enter because they cannot cross the blood-brain barrier.
- The APOE4 isoform is described as producing a dysfunctional apoE that binds neuronal receptors poorly, disrupting neuronal cholesterol handling and, per Dayspring, promoting amyloid production, with Attia citing roughly 2-3x Alzheimer's risk for one E4 copy and about 8-12x for two.
- Plasma desmosterol and 24S-hydroxycholesterol are discussed as biomarkers of brain cholesterol synthesis and excretion, offering a way to think about statin effects on the brain, with Dayspring noting that statins are the only apoB-lowering class that reaches the brain and that trial data show neutrality or benefit for cognition.
- The speakers close with more speculative ideas: ezetimibe's glucuronide metabolite possibly aiding cognition, observational support for omega-3s, and obicetrapib moving Alzheimer's biomarkers in the BROADWAY trial, all awaiting proper clinical trials.
IDEAS WORTH REMEMBERING
5 ideasLowering plasma LDL does not drain the body's or brain's cholesterol
Dayspring says most cholesterol is in cells and almost none relates to circulating levels; Attia notes halving plasma cholesterol reduces total body cholesterol by only a couple of percent.
The brain is a closed cholesterol system
The brain holds about 20 times more cholesterol than the liver, synthesizes its own, and cannot take up apoB particles, so circulating LDL has no bearing on brain cholesterol; a young child's brain grows rapidly despite very low LDL.
Neurons outsource cholesterol production to astrocytes
After about age 10, neurons stop making cholesterol, because synthesis costs over 30 ATP per molecule, and rely on astrocyte-made apoE particles taken up through LRP1, scavenger receptor B1 and the LDL receptor.
APOE4 may impair neuronal cholesterol delivery and promote amyloid
Dayspring argues the E4 isoform binds neuronal receptors poorly, upsetting membrane cholesterol balance where amyloid precursor protein sits and favoring toxic amyloid 42; Attia cites about 2-3x risk for E3/E4 and 8-12x for E4/E4.
Blood sterol markers can reflect brain cholesterol metabolism
Plasma desmosterol correlates highly with CSF and brain levels, and 24S-hydroxycholesterol appears in plasma when neurons offload excess cholesterol; desmosterol is measurable commercially while 24S-hydroxycholesterol is not.
WORDS WORTH SAVING
5 quotesThe brain, of all the organs in the body, has 20 times more cholesterol than does the liver.
— Tom Dayspring
Most people are not aware that the primary function why we have LDLs is to return cholesterol to the liver. Everybody thinks it's delivering cholesterol to cells. Almost never, because every cell can make all the cholesterol it needs.
— Tom Dayspring
Why play Russian roulette and think it's not gonna bother me, when for the vast majority of people, it does create havoc and pathology?
— Tom Dayspring
So physiological levels of circulating cholesterol have nothing to do with a growing or a normal brain.
— Tom Dayspring
The neuron does not wanna waste ATPs making cholesterol if it can get it elsewhere.
— Tom Dayspring
High quality AI-generated summary created from speaker-labeled transcript.
